IP Library Granted Patent US 10,117,760
Granted Patent B2
US 10,117,760 · App. 15/173,312 · Granted Nov 6, 2018

Stent

Inventor: Eric K. Mangiardi (Charlotte, NC)
Assignee: Q3 MEDICAL DEVICES LIMITED
A61F2/82A61B17/7233A61B17/7258A61F2/844A61B17/7266A61B17/7291A61F2002/041A61F2002/048A61F2002/068A61F2002/30289A61F2210/0004A61F2210/0061A61F2230/005A61F2230/0054A61F2230/0091A61F2250/0067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,117,760
App. No.
15/173,312
Granted
Nov 6, 2018
Kind
B2
Abstract

A stent is disclosed that has an elongated body having a proximal end, a distal end, at least one open spiral channel formed on the exterior surface of the body to provide fluid communication between the proximal end and the distal end. The stent also has a central lumen open at the proximal and distal ends of the stent for the passage of a guide wire. A method for using the stent and a kit containing the stent are also disclosed.

Claims (33)

1. A stent comprising:

an elongated body having a proximal end, a distal end, at least one open spiral channel formed on the exterior surface of said body to provide fluid communication between said proximal end and said distal end, and

a central lumen open at the proximal and distal ends of the stent for the passage of a guide wire, wherein the central lumen has a circular, oval or elliptical cross-section and is not in fluid communication with the open spiral channel.

2. The stent of claim 1 , wherein the body is composed of a bioabsorbable polymer.

3. The stent of claim 1 , wherein said at least one open spiral channel has a rotation rate of between about 1.5 and 2.5 twists per inch.

4. The stent of claim 1 , wherein said at least one open spiral channel has a rotation rate of at least about 2 twists per inch.

5. The stent of claim 1 , comprising two open spiral channels formed on the exterior surface of said body.

6. The stent of claim 5 , wherein said channels are on opposite sides on the exterior surface of said body.

7. The stent of claim 1 , wherein said body further comprises an anti-migration device.

8. The stent of claim 1 , wherein said body further comprises a biological agent.

9. The stent of claim 8 , wherein said biological agent is selected from the group consisting of chemotherapeutic agents, antimicrobial agents and gene transfer agents.

10. The stent of claim 1 , wherein said stent has a pre-implantation diameter (D pre ) and is in situ expandable upon absorption of a body fluid to a post-implantation diameter (D post ), wherein D post is greater than D pre .

11. The stent of claim 1 , further comprising a radio-opaque substance.

12. The stent of claim 1 , wherein the open spiral channels are formed integrally on the exterior surface of the elongated body, and

wherein the central lumen has a circular cross-section.

13. A stent comprising:

an elongated body composed of a bioabsorbable polymer and having a proximal end, a distal end, at least one open spiral channel formed on the exterior surface of said body to provide fluid communication between said proximal end and said distal end, wherein said at least one open spiral channel has a rotation rate of at least 1 twist per inch, and

a central lumen open at the proximal and distal ends of the stent for the passage of a guide wire, wherein the central lumen has a circular, oval or elliptical cross-section and is not in fluid communication with the open spiral channel.

14. The stent of claim 13 , wherein said bioabsorbable polymer comprises PEG and p-dioxanone.

15. The stent of claim 13 , wherein said bioabsorbable polymer comprises PPDO.

16. The stent of claim 13 , wherein said bioabsorbable polymer comprises PLA, trimethylene carbonate and caprolactone.

17. The stent of claim 13 , wherein said at least one open spiral channel has a rotation rate of at least about 2 twists per inch.

18. The stent of claim 13 , comprising two open spiral channels formed on the exterior surface of said body.

19. The stent of claim 18 , wherein said channels are on opposite sides on the exterior surface of said body.

20. A stent comprising:

an elongated body having a proximal end, a distal end, at least one open spiral channel formed on the exterior surface of said body to provide fluid communication between said proximal end and said distal end, wherein said at least one open spiral channel has a rotation rate of between about 1.5 and 3.5 twists per inch, and

a central lumen open at the proximal and distal ends of the stent for the passage of a guide wire, wherein the central lumen has a circular, oval or elliptical cross-section and is not in fluid communication with the open spiral channel.

21. The stent of claim 20 , comprising two open spiral channels formed on the exterior surface of said body.

22. The stent of claim 21 , wherein said channels are on opposite sides on the exterior surface of said body.

23. A stent comprising:

an elongated body composed of a bioabsorbable polymer and having a proximal end, a distal end, a pair of open spiral channels formed on the exterior surface of said body to provide fluid communication between said proximal end and said distal end, wherein said spiral channels have a rotation rate of at least about 1 twist per inch, and

a central lumen open at the proximal and distal ends of the stent for the passage of a guide wire, wherein the central lumen has a circular, oval or elliptical cross-section and is not in fluid communication with the open spiral channels.

24. The stent of claim 23 , wherein said channels are on opposite sides on the exterior surface of said body.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: MANGIARDI, ERIC K.
To: Q3 MEDICAL DEVICES LIMITED
Reel/Frame 038975/0838 →
Continuity (4)
Continuation In Part 14841196 · Aug 31, 2015
Continuation 12539314 · Aug 11, 2009
Continuation In Part 12417122 · Apr 2, 2009
Related Publication 20160310299A1 · Oct 27, 2016
Cited By (5)
US 12,268,618 US 12,343,269 US 12,364,840 US 12,440,332 US 12,672,970